Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Prostate Cancer Metastatic × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 298 Lung Neoplasms 160 Breast Neoplasms 131 Ovarian Neoplasms 109 Squamous Cell Carcinoma of Head and Neck 65 Triple Negative Breast Neoplasms 62 Small Cell Lung Carcinoma 52 Fallopian Tube Neoplasms 46 Head and Neck Neoplasms 38 Neoplasms 37 Carcinoma, Ovarian Epithelial 36 Neoplasm Metastasis 34 Adenocarcinoma of Lung 30 Esophageal Neoplasms 27 Prostatic Neoplasms 25 Esophageal Squamous Cell Carcinoma 23 Endometrial Neoplasms 23 Brain Neoplasms 20 Uterine Cervical Neoplasms 19 Carcinoma, Squamous Cell 19 Urinary Bladder Neoplasms 18 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma 17 Central Nervous System Neoplasms 17 Recurrence 16 Neuroblastoma 14 Testicular Neoplasms 13 Oropharyngeal Neoplasms 13 Melanoma 13 Adenocarcinoma, Bronchiolo-Alveolar 13

Interventions

enzalutamide 4 cabazitaxel 3 Docetaxel 3 Prednisone 2 talazoparib 1 rucaparib 1 pembrolizumab 1 olaparib 1 Zuclomiphene 1 XRP6258 1 Radiosurgery 1 Positron Emission Tomography Computed Tomography 1 LY3023414 1 Injections 1 Carboplatin 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05563558 2024-06-11

PEAPOD_FOS

Fundacion Oncosur

Phase 2 Recruiting

Prostate Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡